Language Select
Varian Logo

Press Releases

Maio 23, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Jefferies Global Healthcare... Read more
Maio 22, 2018
Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now received a binding... Read more
Maio 17, 2018
Varian (NYSE: VAR) today announced it has signed a software technology training and education cooperation agreement with the Brazil Ministry of Health (MOH) and seven universities and science and... Read more
Maio 16, 2018
Varian (NYSE: VAR) announced two patients with brain cancer were the first patients in Korea to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type of... Read more
Maio 07, 2018
Varian (NYSE:VAR) today announced it has acquired Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment in Taiwan. COOP currently employs 45 people, and has... Read more
Maio 04, 2018
Varian (NYSE: VAR) today commented on the press release of Sirtex Medical Limited (Sirtex) dated May 4, 2018 announcing that Sirtex had received an unsolicited non-binding, indicative and... Read more
Abril 26, 2018
Varian (NYSE: VAR) today announced Hospital Alemão Oswaldo Cruz in São Paulo, Brazil will be the first hospital in Brazil to install a Halcyon™ treatment system. Scheduled to be installed in... Read more
Abril 25, 2018
Varian (NYSE: VAR) today announced it has signed an agreement with the Stockholm City Council to provide equipment and related services to the radiation therapy department of the New Karolinska... Read more
Abril 25, 2018
Second Quarter 2018 Summary Revenues of $730 million grew 10 percent, or 6 percent in constant currency Oncology gross orders grew 5 percent, or 1 percent in constant currency GAAP operating... Read more
Abril 20, 2018
Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]